Eric Ankerud - Net Worth and Insider Trading
Eric Ankerud Net Worth
The estimated net worth of Eric Ankerud is at least $833,701 dollars as of 2024-11-13. Eric Ankerud is the See Remarks of Ocular Therapeutix Inc and owns about 78,651 shares of Ocular Therapeutix Inc (OCUL) stock worth over $833,701. Details can be seen in Eric Ankerud's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Ankerud has not made any transactions after 2014-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Ankerud
Eric Ankerud Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Ankerud owns 1 companies in total, including Ocular Therapeutix Inc (OCUL) .
Click here to see the complete history of Eric Ankerud’s form 4 insider trades.
Insider Ownership Summary of Eric Ankerud
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2016-02-02 | See Remarks |
Eric Ankerud Latest Holdings Summary
Eric Ankerud currently owns a total of 1 stock. Eric Ankerud owns 78,651 shares of Ocular Therapeutix Inc (OCUL) as of July 30, 2014, with a value of $833,701.
Latest Holdings of Eric Ankerud
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2014-07-30 | 78,651 | 10.60 | 833,701 |
Holding Weightings of Eric Ankerud
Eric Ankerud Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Ankerud has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 1,000 shares on July 30, 2014, which cost Eric Ankerud around $13,000.
Insider Trading History of Eric Ankerud
- 1
Eric Ankerud Trading Performance
GuruFocus tracks the stock performance after each of Eric Ankerud's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Ankerud is 16.62%. GuruFocus also compares Eric Ankerud's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Ankerud within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Ankerud's insider trading performs compared to the benchmark.
Performance of Eric Ankerud
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 27.28 | | | | | |
| Relative Return to S&P 500(%) | 25.59 | | | | | |
Eric Ankerud Ownership Network
Ownership Network List of Eric Ankerud
Ownership Network Relation of Eric Ankerud
Eric Ankerud Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Eric Ankerud is the See Remarks of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Medical Officer Rabia Gurses Ozden .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Eric Ankerud made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Eric Ankerud Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Ankerud. You might contact Eric Ankerud via mailing address: C/o Ocular Therapeutix, Inc., 36 Crosby Dr., Suite 101, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
